Literature DB >> 15215151

Study design questions in treatment of children with acute otitis media.

Alejandro Hoberman, Jack L Paradise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215151      PMCID： PMC434202          DOI： 10.1128/AAC.48.7.2784-2786.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  19 in total

1.  The "in vivo sensitivity test"--bacteriology of middle ear exudate, during antimicrobial therapy in otitis media.

Authors:  V M Howie; J H Ploussard
Journal:  Pediatrics       Date:  1969-12       Impact factor: 7.124

2.  Similarity/equivalence trials for combination vaccines.

Authors:  W C Blackwelder
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

3.  Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.

Authors:  R Dagan; A Hoberman; C Johnson; E L Leibovitz; A Arguedas; F V Rose; B R Wynne; M R Jacobs
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

4.  High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.

Authors:  Antonio Arrieta; Adriano Arguedas; Pilar Fernandez; Stan L Block; Paz Emperanza; Sergio L Vargas; William A Erhardt; Pascal J de Caprariis; Constance D Rothermel
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis.

Authors:  Michael W Dunne; Chandra Khurana; Adriano Arguedas Mohs; Adib Rodriguez; Antonio Arrieta; Samuel McLinn; Judy A Krogstad; Mark Blatter; Richard Schwartz; Sergio L Vargas; Paz Emparanza; Pilar Fernandez; Willis M Gooch; Mary Aspin; John Podgore; Irmeli Roine; Jeffrey L Blumer; Garth D Ehrlich; Jean Chow
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".

Authors:  C D Marchant; S A Carlin; C E Johnson; P A Shurin
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

Review 7.  Rationale for single and high dose treatment regimens with azithromycin.

Authors:  Emma M Gordon; Jeffrey L Blumer
Journal:  Pediatr Infect Dis J       Date:  2004-02       Impact factor: 2.129

8.  Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.

Authors:  Eugene Leibovitz; Lolita Piglansky; Simon Raiz; David Greenberg; Kamal A Hamed; Jean-Marie Ledeine; Joseph Press; Alberto Leiberman; Roger M Echols; Phillip F Pierce; Michael R Jacobs; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

9.  Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure.

Authors:  Adriano Arguedas; Larry Sher; Eduardo Lopez; Xavier Sáez-Llorens; Kamal Hamed; Karen Skuba; Phillip F Pierce
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

10.  Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo.

Authors:  Franz E Babl; Stephen I Pelton; Zhong Li
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.